EXPRESSION XX (20)

NOGGO S33/ Expression XX (20)

SURVEY AMONG PATIENTS WITH GYNECOLOGICAL TUMORS ON HOW TO DELIVER BAD NEWS

Breaking bad news is an essential part of everyday medical practice, especially in gynecologic oncology. Despite the frequency of these conversations, breaking bad news is a considerable challenge for many doctors.

Studies emphasize the need for communication training in order to strengthen the self-confidence of medical staff and reduce the fear of such conversations. To date, however, there have been few studies on this topic, especially in German-speaking countries, which record the perspective of patients when breaking bad news in gynecological oncology. To close this gap, the Expression 20 survey was planned.

What is the aim of the survey?

The aim of this survey is to record and analyze the perspective of female patients when delivering bad news. Differences between women with and without a migration background will be examined. It is assumed that female patients generally see a need for improvement when breaking bad news. In addition, research is to be conducted into whether women with a migration background feel less well informed compared to women without a migration background and whether they have a need for intercultural skills and services.

What is the survey process?

A total of 500 patients will be surveyed for the study. The survey is anonymous and the data will be collected using a questionnaire, which will be available in paper form at the participating study centers. The questionnaire is available in 4 languages – German, Turkish, Arabic and English.

The questionnaire is divided into 2 parts:

  1. Socio-demographic questions:
    15 questions about the person (age, educational status, partnership, mother tongue, place of birth) and the tumor disease
  2. Interview questions:
    46 Questions about a conversation in which bad news about the illness was communicated. The questions relate in particular to the patient’s condition and wishes during this conversation and the time after the conversation.

Are there any risks?

Expression 20 is a survey study and therefore has no participation risks.

Participation requirements

Women with gynecological-oncological tumor diseases including borderline tumors may participate in this survey. The minimum age is 18 years. Only women living in Germany are included.

Where can I take part in the survey?

The study is currently being conducted in Berlin at the Department of Gynecology at Charité’s Virchow Clinic and at Vivantes Klinikum am Urban.

Participation is now also possible online possible!

This study is supported by:

Page last updated on: 23.01.2026